Enable Accessibility Enable Accessibility

Our Pipeline

 

Takeda is an R&D driven, global biopharmaceutical leader. For over 240 years, we’ve focused on bringing better health and a brighter future to people around the world by translating science into life-changing medicines that make a critical difference for patients.

Our R&D engine has produced exciting new molecular entities (NMEs) across our core Therapeutic Areas: Oncology, Rare Genetics and Hematology, Neuroscience and Gastroenterology. In these areas, we’re focused on targeted patient populations where we’re able to deliver the greatest therapeutic benefit for patients.

Takeda’s pipeline is dynamic and diverse—most programs are first-in-class molecules that address areas of high unmet need. We are embracing data and digital technologies to accelerate and complement our pipeline development.

 

Our Pipeline

Late StageDevelopment Programs, Key Proof-Of-Concept Readouts, and Lifecycle Management Milestones

DOWNLOAD THE PDF


Development Pipeline by Phase

DOWNLOAD THE PDF